Tech Company Financing Transactions
Appili Therapeutics Funding Round
Appili Therapeutics closed a $3.1 million Seed financing round on 10/24/2017. Backers included Innovacorp and private investors.
Transaction Overview
Company Name
Announced On
10/24/2017
Transaction Type
Venture Equity
Amount
$3,062,000
Round
Seed
Investors
Innovacorp (Lidija Maru�ic)
Proceeds Purpose
Proceeds from the financing will be used to fund operations and the continued growth of the company. Specifically, the additional funding will enable Appili to advance its pipeline of anti-infectives and move its lead antibiotic, a taste-masked treatment for anaerobic infections, into the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1344 Summer St. 21
Halifax NS, B3H 0A8
Canada
Halifax NS, B3H 0A8
Canada
Phone
Website
Email Address
Overview
Appili Therapeutics is developing novel approaches to lead the fight against infectious disease. Despite numerous achievements in the development of anti-infectives, infectious disease remains the leading cause of death worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Sullivan
Chief Financial Officer
Kimberly Stephens
VP - Bus. Development
Armand Balboni
VP - Manufacturing
Myriam Triest
Browse more venture capital transactions:
Prev: 10/24/2017: ActionIQ venture capital transaction
Next: 10/24/2017: Vouchr venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs